Skip Nav Destination
Issues
15 July 2016
-
Cover Image
Cover Image
The cover shows intratumoral bone deposition, shown by strong Alizarin Red staining, in a malignant rhabdoid tumor xenograft treated with low-dose LBH589. For details, see the article by Muscat and colleagues on page 3560 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Molecular Pathways
Review
Cancer Therapy: Clinical
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera; Martin Felices; Ron McElmurry; Valarie McCullar; Xianzheng Zhou; Joerg Uwe Schmohl; Bin Zhang; Alexander J. Lenvik; Angela Panoskaltsis-Mortari; Michael R. Verneris; Jakub Tolar; Sarah Cooley; Daniel J. Weisdorf; Bruce R. Blazar; Jeffrey S. Miller
High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma
Anna E. Coghill; Wei Bu; Hanh Nguyen; Wan-Lun Hsu; Kelly J. Yu; Pei-Jen Lou; Cheng-Ping Wang; Chien-Jen Chen; Allan Hildesheim; Jeffrey I. Cohen
Personalized Medicine and Imaging
Author Choice
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair–Proficient Stage II Colon Cancer
Pradipta Ghosh; Jeanne Tie; Andrea Muranyi; Shalini Singh; Patrick Brunhoeber; Katherine Leith; Rebecca Bowermaster; Zhiming Liao; Yifei Zhu; Bonnie LaFleur; Ben Tran; Jayesh Desai; Ian Jones; Matthew Croxford; Rodrigo Jover; Ajay Goel; Paul Waring; Song Hu; Volker Teichgraber; Ulrich-Peter Rohr; Ruediger Ridder; Kandavel Shanmugam; Peter Gibbs
Cancer Therapy: Preclinical
Author Choice
TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
Licia Rivoltini; Claudia Chiodoni; Paola Squarcina; Monica Tortoreto; Antonello Villa; Barbara Vergani; Maja Bürdek; Laura Botti; Ivano Arioli; Agata Cova; Giorgio Mauri; Elisabetta Vergani; Beatrice Bianchi; Pamela Della Mina; Laura Cantone; Valentina Bollati; Nadia Zaffaroni; Alessandro Massimo Gianni; Mario Paolo Colombo; Veronica Huber
Methionine and Kynurenine Activate Oncogenic Kinases in Glioblastoma, and Methionine Deprivation Compromises Proliferation
Kamalakannan Palanichamy; Krishnan Thirumoorthy; Suman Kanji; Nicolaus Gordon; Rajbir Singh; John R. Jacob; Nikhil Sebastian; Kevin T. Litzenberg; Disha Patel; Emily Bassett; Brinda Ramasubramanian; Tim Lautenschlaeger; Steven M. Fischer; Abhik Ray-Chaudhury; Arnab Chakravarti
Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis
Subapriya Rajamanickam; Subbarayalu Panneerdoss; Aparna Gorthi; Santosh Timilsina; Benjamin Onyeagucha; Dmytro Kovalskyy; Dmitri Ivanov; Martha A. Hanes; Ratna K. Vadlamudi; Yidong Chen; Alexander J. Bishop; Jack L. Arbiser; Manjeet K. Rao
HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia
Tsung-Huei Lai; Brett Ewald; Alma Zecevic; Chaomei Liu; Melanie Sulda; Dimitrios Papaioannou; Ramiro Garzon; James S. Blachly; William Plunkett; Deepa Sampath
Targeting MDM2 for Treatment of Adenoid Cystic Carcinoma
Kristy A. Warner; Felipe Nör; Gerson A. Acasigua; Manoela D. Martins; Zhaocheng Zhang; Scott A. McLean; Matthew E. Spector; Douglas B. Chepeha; Joseph Helman; Michael J. Wick; Christopher A. Moskaluk; Rogerio M. Castilho; Alexander T. Pearson; Shaomeng Wang; Jacques E. Nör
Author Choice
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors
Andrea Muscat; Dean Popovski; W. Samantha N. Jayasekara; Fernando J. Rossello; Melissa Ferguson; Kieren D. Marini; Muhammad Alamgeer; Elizabeth M. Algar; Peter Downie; D. Neil Watkins; Jason E. Cain; David M. Ashley
Biology of Human Tumors
Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma
Zijun Y. Xu-Monette; Qipan Deng; Ganiraju C. Manyam; Alexander Tzankov; Ling Li; Yi Xia; Xiao-xiao Wang; Dehui Zou; Carlo Visco; Karen Dybkær; Jun Li; Li Zhang; Han Liang; Santiago Montes-Moreno; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L. Richards; Eric D. Hsi; William W.L. Choi; J. Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J.M. Ferreri; Ben M. Parsons; Michael B. Møller; Sa A. Wang; Roberto N. Miranda; Miguel A. Piris; Jane N. Winter; L. Jeffrey Medeiros; Yong Li; Ken H. Young
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets
Natasha Rekhtman; Maria C. Pietanza; Matthew D. Hellmann; Jarushka Naidoo; Arshi Arora; Helen Won; Darragh F. Halpenny; Hangjun Wang; Shaozhou K. Tian; Anya M. Litvak; Paul K. Paik; Alexander E. Drilon; Nicholas Socci; John T. Poirier; Ronglai Shen; Michael F. Berger; Andre L. Moreira; William D. Travis; Charles M. Rudin; Marc Ladanyi
Author Choice
Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma
Yanyan Lou; Lixia Diao; Edwin Roger Parra Cuentas; Warren L. Denning; Limo Chen; You Hong Fan; Lauren A. Byers; Jing Wang; Vassiliki A. Papadimitrakopoulou; Carmen Behrens; Jaime Canales Rodriguez; Patrick Hwu; Ignacio I. Wistuba; John V. Heymach; Don L. Gibbons
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group
Kieuhoa T. Vo; Jeremy V. Edwards; C. Lorrie Epling; Elizabeth Sinclair; Douglas S. Hawkins; Holcombe E. Grier; Katherine A. Janeway; Phillip Barnette; Elizabeth McIlvaine; Mark D. Krailo; Donald A. Barkauskas; Katherine K. Matthay; Richard B. Womer; Richard G. Gorlick; Stephen L. Lessnick; Crystal L. Mackall; Steven G. DuBois
Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer
Maya Dadiani; Noa Bossel Ben-Moshe; Shani Paluch-Shimon; Gili Perry; Nora Balint; Irina Marin; Anya Pavlovski; Dana Morzaev; Smadar Kahana-Edwin; Ady Yosepovich; Einav Nili Gal-Yam; Raanan Berger; Iris Barshack; Eytan Domany; Bella Kaufman
Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non–Small Cell Lung Cancer: Double-Edged Sword of DDR2
Masato Terashima; Yosuke Togashi; Katsuaki Sato; Hiroshi Mizuuchi; Kazuko Sakai; Kenichi Suda; Yu Nakamura; Eri Banno; Hidetoshi Hayashi; Marco A. De Velasco; Yoshihiko Fujita; Shuta Tomida; Tetsuya Mitsudomi; Kazuto Nishio
ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer
Shuai Gao; Huihui Ye; Sean Gerrin; Hongyun Wang; Ankur Sharma; Sen Chen; Akash Patnaik; Adam G. Sowalsky; Olga Voznesensky; Wanting Han; Ziyang Yu; Elahe A. Mostaghel; Peter S. Nelson; Mary-Ellen Taplin; Steven P. Balk; Changmeng Cai
Author Choice
Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays
Apurva K. Srivastava; Melinda G. Hollingshead; Jennifer Weiner; Tony Navas; Yvonne A. Evrard; Sonny A. Khin; Jiuping Jay Ji; Yiping Zhang; Suzanne Borgel; Thomas D. Pfister; Robert J. Kinders; Donald P. Bottaro; W. Marston Linehan; Joseph E. Tomaszewski; James H. Doroshow; Ralph E. Parchment
Obituary
Letters to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.